AKB-10108

N/A

Report date: 2024/03/20 17:17:04

Base Information

Drug NameAKB-10108
Drug Alias NameAKB-10108
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHypoxia-inducible factor prolyl hydroxylase inhibitors
TargetsHypoxia-inducible factor prolyl hydroxylase
Therapy Area/IndicationsRetinopathy of PrematurityBronchopulmonary Dysplasia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAkebia Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesAkebia Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsRetinopathy of PrematurityBronchopulmonary Dysplasia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A